SPONSOR
Central Institute of Mental Health, Mannheim
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: SchizophreniaTreatment Resistant SchizophreniaAlcohol AddictionAlcoholismSchizophrenia Spectrum Disorders (SSD)
Central Institute of Mental Health, Mannheim is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Schizophrenia, Treatment Resistant Schizophrenia, Alcohol Addiction, Alcoholism.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Central Institute of Mental Health, Mannheim
How many clinical trials has Central Institute of Mental Health, Mannheim sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Central Institute of Mental Health, Mannheim, of which 3 are actively recruiting participants. These trials cover conditions including Schizophrenia, Treatment Resistant Schizophrenia, Alcohol Addiction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Central Institute of Mental Health, Mannheim research focus on?
Central Institute of Mental Health, Mannheim clinical trials span Schizophrenia, Treatment Resistant Schizophrenia, Alcohol Addiction, Alcoholism, Schizophrenia Spectrum Disorders (SSD). The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Central Institute of Mental Health, Mannheim clinical trial?
To participate in a Central Institute of Mental Health, Mannheim trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Central Institute of Mental Health, Mannheim trials with current recruitment status updated daily.
Clinical Trials by Central Institute of Mental Health, Mannheim
NCT06456983
Recruiting
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Schizophrenia
NCT06845124 Phase 2
Recruiting
A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence
Alcohol Addiction
NCT06881810 Phase 2
Recruiting
Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment
Schizophrenia Spectrum Disorders (SSD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology